27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Incyte (NASDAQ:INCY) were unchanged after the company reported Q1 results.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Quarterly Results
Earnings per share increased 123.43% year over year to $0.67, which beat the estimate of $0.64.
Revenue of $604,718,000 higher by 6.37% year over year, which missed the estimate of $659,240,000.
Guidance
Incyte reaffirmed FY21 Jakafi net product revenues of $2.125 billion-$2.2 billion.
Details Of The Call
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Date: May 04, 2021
Time: 08:00 AM
ET Webcast URL: https://event.webcasts.com/starthere.jsp?ei=1449405&tp_key=2fec8b29bf
Price Action
52-week high: $110.36
52-week low: $75.52
Price action over last quarter: Up 0.41%
Company Overview
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). Incyte's pipeline includes a broad array of oncology and dermatology programs.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.